Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine

Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologie...

Descripción completa

Detalles Bibliográficos
Autores principales: Risum, Signe, Knigge, Ulrich, Langer, Seppo W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715430/
https://www.ncbi.nlm.nih.gov/pubmed/29225862
http://dx.doi.org/10.1002/ccr3.1262
_version_ 1783283766429483008
author Risum, Signe
Knigge, Ulrich
Langer, Seppo W.
author_facet Risum, Signe
Knigge, Ulrich
Langer, Seppo W.
author_sort Risum, Signe
collection PubMed
description Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologies in cancer diagnostic and treatment.
format Online
Article
Text
id pubmed-5715430
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-57154302017-12-08 Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine Risum, Signe Knigge, Ulrich Langer, Seppo W. Clin Case Rep Case Reports Survival of stage 4 ganglioneuroblastoma (GNB) patients is poor; no reports exist of patients surviving up to 5 years (1, 2). We report the clinical and therapeutic course of a patient with stage 4 GNB surviving beyond expectations due to a multimodal treatment approach incorporating new technologies in cancer diagnostic and treatment. John Wiley and Sons Inc. 2017-11-07 /pmc/articles/PMC5715430/ /pubmed/29225862 http://dx.doi.org/10.1002/ccr3.1262 Text en © 2017 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Risum, Signe
Knigge, Ulrich
Langer, Seppo W.
Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
title Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
title_full Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
title_fullStr Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
title_full_unstemmed Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
title_short Hitherto unseen survival in an ALK‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
title_sort hitherto unseen survival in an alk‐positive‐patient with advanced stage adult ganglioneuroblastoma treated with personalized medicine
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5715430/
https://www.ncbi.nlm.nih.gov/pubmed/29225862
http://dx.doi.org/10.1002/ccr3.1262
work_keys_str_mv AT risumsigne hithertounseensurvivalinanalkpositivepatientwithadvancedstageadultganglioneuroblastomatreatedwithpersonalizedmedicine
AT kniggeulrich hithertounseensurvivalinanalkpositivepatientwithadvancedstageadultganglioneuroblastomatreatedwithpersonalizedmedicine
AT langerseppow hithertounseensurvivalinanalkpositivepatientwithadvancedstageadultganglioneuroblastomatreatedwithpersonalizedmedicine

Ejemplares similares